Key result
Diagnosis of insulin resistance syndrome may allow clinicians to diagnose and treat atherosclerosis at an early stage to stop or reverse vascular damage.
Why the study?
Does the diagnosis of insulin resistance syndrome allow clinicians to diagnose and treat atherosclerosis at an early stage?
Does the diagnosis of insulin resistance syndrome allow clinicians to diagnose and treat atherosclerosis at an early stage?
Diagnosing insulin resistance syndrome may help clinicians identify and treat atherosclerosis early to prevent or reverse vascular damage.
May prompt earlier atherosclerosis screening in insulin-resistant patients; leaves open need for prospective outcome trials.
The aim of this paper is to review the literature regarding the metabolic syndrome and the single factor that links all its core components. That single factor seems to be partial insulin deficiency (PID), which is responsible for varying degrees of atherosclerotic vascular damage. In conclusion, we found that the diagnosis of insulin resistance syndrome (IRS) may allow clinicians to diagnose and treat atherosclerosis at an early stage-to stop or reverse vascular damage.
No takes yet. Share an insight, caveat, or question.
D Virsaladze (2006) conducted a review in Metabolic syndrome. Diagnosis of insulin resistance syndrome was evaluated. Diagnosis of insulin resistance syndrome may allow clinicians to diagnose and treat atherosclerosis at an early stage to stop or reverse vascular damage.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: